Cancer Biomarkers
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 21.0% | 0.572 | Q2 | 66.0% |
| 2024 | 1.9 | Q3 | 26.1% | 0.586 | Q2 | 67.7% |
| 2023 | 2.2 | Q3 | 34.9% | 0.579 | Q2 | 69.7% |
| 2022 | 3.1 | Q3 | 45.1% | 0.622 | Q2 | 73.2% |
| 2021 | 3.8 | Q3 | 52.9% | 0.688 | Q2 | 76.9% |
| 2020 | — | — | 0.959 | Q1 | 84.4% | |
| 2019 | — | — | 0.874 | Q1 | 82.5% | |
| 2018 | — | — | 0.839 | Q2 | 79.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1875-8592
ISSN
1574-0153
country
GBcoverage
2005-2025